| |
|
|
|
|
|
|
|||
|
S Sekhsaria and HL Malech
Laboratory of Host Defenses, National Institute of Allergy and Infectious
Disease, National Institutes of Health, Bethesda, MD 20892.
Peripheral blood hematopoietic progenitors (PBHP) are capable of colony
growth in vitro. The effect of stem cell factor (SCF), interleukin-6
(IL-6), and basic fibroblast growth factor (bFGF) on myeloid colony
proliferation of PBHP was determined. PBHP purified by positive selection
with CD34-specific antibody were plated in semisolid agarose with reported
plateau doses of interleukin-3 (IL-3), granulocyte- macrophage
colony-stimulating factor (GM-CSF), and granulocyte colony- stimulating
factor (G-CSF) to enhance myeloid colony growth. Experiments then were done
to examine colony growth in response to SCF or with SCF and bFGF and/or
IL6. SCF alone in the absence of any other growth factors did not support
colony growth. SCF at a determined optimum concentration of 100 ng/mL added
to the combination of IL-3, GM- CSF, and G-CSF enhanced colony growth and
size relative to proliferation in response to the latter three factors
alone (from 78 to 188 total colonies/10(4) PBHP plated and from 10 to 93
large [> 200 cells] colonies/10(4) PBHP plated). Furthermore, addition
of bFGF and/or IL-6 to the combination of optimum concentrations of SCF,
IL-3, GM-CSF, and G-CSF further enhanced colony number and size in a dose-
dependent fashion. Using the optimum combination of all growth factors, we
determined that the number of myeloid colony-forming PBHP in whole blood
was similar between individuals at about three colonies per milliliter
whole blood. We conclude that progenitors capable of responding to the
early-acting growth factor, SCF, are represented in PBHP and that the
number of circulating myeloid colony-forming PBHP is likely a regulated
parameter that may have an important biologic function.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1993 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||